Advent Pharma Ltd. (DSE:ADVENT)

Market Cap	1.31B -5.4%
Revenue (ttm)	458.15M -4.3%
Net Income	48.03M -1.3%
EPS	0.52 -0.7%
Shares Out	93.13M
PE Ratio	27.17
Forward PE	n/a
Dividend	0.05 (0.35%)
Ex-Dividend Date	Nov 23, 2025

Volume	50,219
Open	14.30
Previous Close	14.00
Day's Range	14.00 - 14.40
52-Week Range	11.50 - 17.10
Beta	0.30
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 26, 2026

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 317
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ADVENT

Financial Performance

In fiscal year 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 25, 2026

Data Sources Report a data error